Key terms
About BIVI
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BIVI news
Mar 18
8:45am ET
Largest borrow rate increases among liquid names
Mar 11
8:16am ET
BioVie announces pipeline update, near-term priorities
Mar 06
5:23pm ET
BioVie Strengthens Capital with $21M Public Offering
Mar 04
8:49am ET
BioVie sells 21M shares at $1.50 in ‘best efforts’ public offering
Mar 01
5:00pm ET
BioVie announces common stock offering, no amount given
Mar 01
8:05am ET
BioVie announces two upcoming presentations on NE3107
Feb 29
7:01pm ET
SHAREHOLDER ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors
Jan 26
4:51am ET
BioVie Faces Class Action Lawsuit Over Drug Trial Claims
Jan 22
2:35pm ET
SHAREHOLDER ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors
Jan 02
8:45am ET
Largest borrow rate increases among liquid names
No recent news articles are available for BIVI
Mar 19
10:41am ET
DEADLINE TODAY: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm
Mar 18
5:12pm ET
BIVI DEADLINE TOMORROW: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIVI
Mar 18
12:12pm ET
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie
Mar 18
11:05am ET
DEADLINE TOMORROW: Berger Montague Advises BioVie Inc. (BIVI) Investors to Inquire About a Securities Fraud Class Action by March 19, 2024
Mar 18
10:40am ET
DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm
Mar 17
5:06pm ET
BIVI DEADLINE ALERT: TOP RANKED ROSEN LAW FIRM Encourages BioVie Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BIVI
Mar 17
9:41am ET
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie
Mar 16
2:45pm ET
BIVI DEADLINE ALERT: TOP RANKED ROSEN LAW FIRM Encourages BioVie Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI
Mar 16
9:32am ET
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie
Mar 15
12:06pm ET
Berger Montague Advises BioVie Inc. (BIVI) Investors to Inquire About a Securities Fraud Class Action by Tuesday, March 19, 2024
Mar 15
11:14am ET
TUESDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm
Mar 14
1:34pm ET
BIVI DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI
Mar 14
7:13am ET
TUESDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm
Mar 13
3:18pm ET
BIVI 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investors with Substantial Losses to Contact its Attorneys Before Mar. 19th Deadline in Securities Fraud Class Action Over Failed Phase 3 Clinical Trial
Mar 13
7:12am ET
TUESDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm
Mar 13
6:01am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines - BIVI
Mar 13
2:36am ET
SHAREHOLDER REMINDER: Berger Montague Reminds BioVie Inc. (BIVI) Investors of the March 19, 2024 Deadline
Mar 12
7:11am ET
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm
BIVI Financials
Key terms
Ad Feedback
BIVI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BIVI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range